AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2010
Apr 8, 2010
34519_dirs_2010-04-08_b2434865-4b80-4271-b8b5-f872876f4dad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-04-08
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-04-08 | Common Stock, par value $0.10 per share | J | 89 | $0.00 | Acquired | 458970 | Direct |
Footnotes
F1: This figure includes 213,255 shares of common stock held by Arterio, Inc., a company owned solely by Mr. Rothschild. This amendment is being filed to correct an immaterial understatement in the amount of 89 shares in the total number of shares controlled by Mr. Rothschild and to correct the allocation of shares held in Mr. Rothschild's personal account as opposed to the account of Arterio, Inc.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23